The industry urgently needs to understand that its current approach to policy is almost pre-destined to deliver disappointment and poor outcomes. …
The choice is to be more defensive or continue to suffer bad outcomes
September 19, 2022 Latest NewsBioPharmaComment
Latest Video
New Stories
-
Omico opens a new chapter in precision oncology research
June 1, 2026 - - Latest News -
Ex-MA executive named the first CEO of Medicinal Cannabis Council Australia
June 1, 2026 - - Latest News -
Oral RAS inhibitor doubles median survival and cuts death risk in metastatic pancreatic cancer
June 1, 2026 - - Latest News -
Australia risks losing more than jobs in its biopharmaceutical sector — it risks losing strategic capability
June 1, 2026 - - Latest News -
New PBS listings expand access to blood cancer therapies
June 1, 2026 - - Latest News -
Now you can see the next step in the process most are officially excluded from
June 1, 2026 - - Latest News -
Australia's HTA Review closed-loop process continues with 'Delphi' stage two
June 1, 2026 - - Latest News